Justin M. David

1.8k total citations
30 papers, 1.4k citations indexed

About

Justin M. David is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Justin M. David has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 14 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Justin M. David's work include Cancer Cells and Metastasis (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Immunotherapy and Immune Responses (5 papers). Justin M. David is often cited by papers focused on Cancer Cells and Metastasis (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Immunotherapy and Immune Responses (5 papers). Justin M. David collaborates with scholars based in United States, Spain and Denmark. Justin M. David's co-authors include Claudia Palena, Charli Dominguez, Duane H. Hamilton, Ayyappan K. Rajasekaran, Kristen K. McCampbell, Jeffrey Schlom, James L. Gulley, Kwong Y. Tsang, Massimo Fantini and Romaine I. Fernando and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Justin M. David

28 papers receiving 1.4k citations

Peers

Justin M. David

ONCOL

IMMUN

PRM

Dennis O. Adeegbe United States

Pablo Matar Argentina

Bo Zhu China

Meggy Suarez‐Carmona Belgium

Stephan Fricke Germany

Sara Tomei Qatar

Sachi Horibata United States

Michele Minopoli Italy

Shailendra K. Gautam United States

Ángel García-Díaz Spain

Dennis O. Adeegbe United States

Justin M. David

845 ×1.1

ONCOL

1.2k ×2.2

IMMUN

487 ×0.9

232 ×1.1

PRM

164 ×0.8

Citations per year, relative to Justin M. David Justin M. David (= 1×) peers Dennis O. Adeegbe

Countries citing papers authored by Justin M. David

Since Specialization

Citations

This map shows the geographic impact of Justin M. David's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justin M. David with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justin M. David more than expected).

Fields of papers citing papers by Justin M. David

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justin M. David. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justin M. David. The network helps show where Justin M. David may publish in the future.

Co-authorship network of co-authors of Justin M. David

This figure shows the co-authorship network connecting the top 25 collaborators of Justin M. David. A scholar is included among the top collaborators of Justin M. David based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justin M. David. Justin M. David is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Galsky, Matthew D., Dean F. Bajorin, Yoshihiko Tomita, et al.. (2025). Adjuvant nivolumab in muscle-invasive urothelial carcinoma: exploratory biomarker analysis of the randomized phase 3 CheckMate 274 trial. Nature Medicine. 31(9). 3062–3073.

Garman, Bradley, Can Jiang, Sherif Daouti, et al.. (2023). Comprehensive immunophenotyping of solid tumor-infiltrating immune cells reveals the expression characteristics of LAG-3 and its ligands. Frontiers in Immunology. 14. 1151748–1151748. 9 indexed citations

Fantini, Massimo, et al.. (2020). The Monoclonal Antibody NEO-201 Enhances Natural Killer Cell Cytotoxicity Against Tumor Cells Through Blockade of the Inhibitory CEACAM5/CEACAM1 Immune Checkpoint Pathway. Cancer Biotherapy and Radiopharmaceuticals. 35(3). 190–198. 13 indexed citations

Zeligs, Kristen, Maria Pia Morelli, Justin M. David, et al.. (2020). Evaluation of the Anti-Tumor Activity of the Humanized Monoclonal Antibody NEO-201 in Preclinical Models of Ovarian Cancer. Frontiers in Oncology. 10. 805–805. 8 indexed citations

Fantini, Massimo, Justin M. David, Hing C. Wong, et al.. (2019). An IL-15 Superagonist, ALT-803, Enhances Antibody-Dependent Cell-Mediated Cytotoxicity Elicited by the Monoclonal Antibody NEO-201 Against Human Carcinoma Cells. Cancer Biotherapy and Radiopharmaceuticals. 34(3). 147–159. 20 indexed citations

Fantini, Massimo, Justin M. David, Alexander Dubeykovskiy, et al.. (2018). Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas. Frontiers in Immunology. 8. 1899–1899. 16 indexed citations

David, Justin M., Massimo Fantini, Christina M. Annunziata, Philip M. Arlen, & Kwong Y. Tsang. (2018). Abstract 3821: The neoantigen-targeting antibody NEO-201 enhances NK cell-dependent killing of tumor cells through blockade of the inhibitory CEACAM5/CEACAM1 immune checkpoint pathway. Cancer Research. 78(13_Supplement). 3821–3821. 2 indexed citations

Dominguez, Charli, Justin M. David, & Claudia Palena. (2017). Epithelial-mesenchymal transition and inflammation at the site of the primary tumor. Seminars in Cancer Biology. 47. 177–184. 119 indexed citations

Tsang, Kwong Y., Massimo Fantini, Romaine I. Fernando, et al.. (2017). Identification and characterization of enhancer agonist human cytotoxic T-cell epitopes of the human papillomavirus type 16 (HPV16) E6/E7. Vaccine. 35(19). 2605–2611. 16 indexed citations

10.

Shah, Sagar, Justin M. David, Nathaniel D. Tippens, et al.. (2017). Brachyury-YAP Regulatory Axis Drives Stemness and Growth in Cancer. Cell Reports. 21(2). 495–507. 54 indexed citations

11.

Hamilton, Duane H., Justin M. David, Charli Dominguez, & Claudia Palena. (2017). Development of Cancer Vaccines Targeting Brachyury, a Transcription Factor Associated with Tumor Epithelial-Mesenchymal Transition. Cells Tissues Organs. 203(2). 128–138. 17 indexed citations

12.

Hamilton, Duane H., Lesley A. Mathews Griner, Jonathan M. Keller, et al.. (2016). Targeting Estrogen Receptor Signaling with Fulvestrant Enhances Immune and Chemotherapy-Mediated Cytotoxicity of Human Lung Cancer. Clinical Cancer Research. 22(24). 6204–6216. 48 indexed citations

13.

David, Justin M., Charli Dominguez, & Claudia Palena. (2016). Pharmacological and immunological targeting of tumor mesenchymalization. Pharmacology & Therapeutics. 170. 212–225. 14 indexed citations

14.

Fernando, Romaine I., Duane H. Hamilton, Charli Dominguez, et al.. (2016). IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib. Oncotarget. 7(27). 42031–42044. 51 indexed citations

15.

David, Justin M., Duane H. Hamilton, & Claudia Palena. (2016). MUC1 upregulation promotes immune resistance in tumor cells undergoing brachyury-mediated epithelial-mesenchymal transition. OncoImmunology. 5(4). e1117738–e1117738. 54 indexed citations

16.

David, Justin M. & Ayyappan K. Rajasekaran. (2015). Gramicidin A: A New Mission for an Old Antibiotic. SHILAP Revista de lepidopterología. 2(1). 15–24. 48 indexed citations

17.

David, Justin M., et al.. (2014). Gramicidin A Blocks Tumor Growth and Angiogenesis through Inhibition of Hypoxia-Inducible Factor in Renal Cell Carcinoma. Molecular Cancer Therapeutics. 13(4). 788–799. 20 indexed citations

18.

Selvakumar, Ponniah, Justin M. David, Nicholas J. Petrelli, et al.. (2014). Epigenetic silencing of Na,K-ATPase β₁subunit geneATP1B1by methylation in clear cell renal cell carcinoma. Epigenetics. 9(4). 579–586. 31 indexed citations

19.

Sampson, Valerie B., Justin M. David, Isabel Puig, et al.. (2014). Wilms' Tumor Protein Induces an Epithelial-Mesenchymal Hybrid Differentiation State in Clear Cell Renal Cell Carcinoma. PLoS ONE. 9(7). e102041–e102041. 54 indexed citations

20.

David, Justin M., Duane H. Hamilton, Jeffrey Schlom, & Claudia Palena. (2014). The role of oncogenic MUC1-C in brachyury-induced immunotherapy resistance. Journal for ImmunoTherapy of Cancer. 2(S3).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact